Clinical pharmacology and therapeutics Journal

Overview

publication venue for

Treatment of urinary incontinence with anticholinergics in patients taking cholinesterase inhibitors for dementia. 2004
Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of Nephrotoxicity. 2025
Quantitative Systems Toxicology Modeling Informed Safe Dose Selection of Emvododstat in Acute Myeloid Leukemia Patients.. 115. 2023
Angiotensin-Converting Enzyme Inhibitors Used Concomitantly with Insulin Secretagogues and the Risk of Serious Hypoglycemia.. 111. 2021
Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors and Sudden Cardiac Arrest and Ventricular Arrhythmia: Population-Based Cohort Studies.. 111. 2021
Pharmacokinetics and Drug-Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping.. 109. 2020
Response to Inhibition of Receptor-Interacting Protein Kinase 1 (RIPK1) in Active Plaque Psoriasis: A Randomized Placebo-Controlled Study.. 108. 2020
Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics.. 99. 2016
Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and age.. 90. 2011
Estrogen receptor genotypes, menopausal status, and the effects of tamoxifen on lipid levels: revised and updated results.. 88. 2010
Integration of genetic, clinical, and INR data to refine warfarin dosing.. 87. 2010
A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphoma.. 86. 2009
The Reference Image Database to Evaluate Response to therapy in lung cancer (RIDER) project: a resource for the development of change-analysis software.. 84. 2008
Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen.. 83. 2007
Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment.. 80. 2006
Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation.. 78. 2005
Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers.. 78. 2005
Abciximab pharmacodynamic model with neural networks used to integrate sources of patient variability.. 75. 2004
Pharmacodynamics of abciximab during angioplasty: comparison to healthy subjects.. 71. 2002
Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in mice.. 65. 1999
Drug-related hospitalization at a tertiary teaching center in Lebanon: incidence, associations, and relation to self-medicating behavior.. 64. 1998
Transdermal versus subcutaneous leuprolide: a comparison of acute pharmacodynamic effect.. 48. 1990
Dopamine clearance in critically ill infants and children: effect of age and organ system dysfunction.. 48. 1990
Reversal of a calcium-mediated vasoconstrictor component in patients with congestive heart failure.. 46. 1989
Increased renal tubular cell excretion by patients receiving chronic therapy with gold and with nonsteroidal anti-inflammatory drugs.. 46. 1989
Successful transdermal administration of therapeutic doses of a polypeptide to normal human volunteers.. 44. 1988
Hydromorphone levels and pain control in patients with severe chronic pain.. 44. 1988
Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndrome.. 42. 1987
Metoclopramide decreases renal plasma flow.. 39. 1986
Plasma 10-hydroxynortriptyline in elderly depressed patients.. 35. 1984
Determinants of response to anorexiants.. 30. 1981
Treatment of malignant melanoma with methyl CCNU.. 15. 1974
Biotechnology and therapeutics. 1993
Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop Summary. 2022
Emerging Innovative Therapeutic Approaches Leveraging Cyclin-Dependent Kinase Inhibitors to Treat Advanced Breast Cancer. 2018
Tyrosine Kinase Inhibitors and Male Reproductive Health. 2017
Optimizing treatment for patients with anaplastic lymphoma kinase-positive lung cancer. 2017
New drug targets for the treatment of obesity. 2011
New targets for obesity pharmacotherapy. 2007
Biotechnology and therapeutics: expensive treatments and limited resources. A view from the hospital. 1992
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing. 2015

Identity

ISO Abbreviation

Clin Pharmacol Ther

Linking ISSN

0009-9236

International Standard Serial Number (ISSN)

0009-9236

Electronic International Standard Serial Number (EISSN)

1532-6535